Advertisement
Advertisement
QNTM
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
4.13
USDSponsored
+0.21
+5.48%
Feb 06, 14:05 UTC -5
Closed
After-Market
4.13
0.00
-0.12%
QNTM Earnings Reports
Positive Surprise Ratio
QNTM beat 2 of 5 last estimates.
40%
Next Report
Date of Next Report
Mar 26, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
--
/--
Implied change from Q4 24 (Revenue/ EPS)
--
/--
Quantum Biopharma Ltd. Class B Subordinate Voting Shares earnings per share and revenue
On Nov 07, 2025, QNTM reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
AYTU BioPharma, Inc. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
-$0.61
Actual
-$1.05
Surprise
-71.57%
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Bristol-Myers Squibb Co.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.12
Actual
$1.26
Surprise
+11.88%
GSK plc - ADR
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.23
Actual
$0.49
Surprise
+111.36%
Biogen Inc. Common Stock
Report Date
Feb 06, 2026 For Q4 25
Estimate
$1.62
Actual
$1.99
Surprise
+22.39%
Illumina Inc
Report Date
Feb 05, 2026 For Q4 25
Estimate
$1.24
Actual
$1.35
Surprise
+8.01%
QIAGEN N.V.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.64
Actual
$0.62
Surprise
-3.32%
Arrowhead Research Corporation
Report Date
Feb 05, 2026 For Q1 26
Estimate
$0.25
Actual
$0.22
Surprise
-14.76%
Bio-Techne Corp.
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.44
Actual
$0.46
Surprise
+3.95%
Immunovant, Inc. Common Stock
Report Date
Feb 06, 2026 For Q3 26
Estimate
-$0.72
Actual
-$0.61
Surprise
+16.27%
FAQ
What were Quantum Biopharma Ltd. Class B Subordinate Voting Shares's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Quantum Biopharma Ltd. Class B Subordinate Voting Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Quantum Biopharma Ltd. Class B Subordinate Voting Shares's Q3 2025 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Quantum Biopharma Ltd. Class B Subordinate Voting Shares expected to report next?
The next earning report is scheduled for Mar 26, 2026.
What are the forecasts for Quantum Biopharma Ltd. Class B Subordinate Voting Shares's next earnings report?
Based on --
analysts, Quantum Biopharma Ltd. Class B Subordinate Voting Shares is expected to report EPS of -- and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement